Skip to main content

María José Buzón Gómez

I am a researcher with extensive training in virology and immunology and a strong interest in translational research. I am dedicated to the study of new therapies aimed at curing HIV, with special emphasis on the characterization, both in blood and in different tissues, of new cellular reservoirs of HIV and the development of strategies that enhance the immune system. Recently part of my research has been directed to the study of SARS-CoV-2.

Institutions of which they are part

Head of group
Infectious Diseases
Vall Hebron Institut de Recerca

María José Buzón Gómez

Institutions of which they are part

Head of group
Infectious Diseases
Vall Hebron Institut de Recerca

I am a researcher with extensive training in virology and immunology and a strong interest in translational research. I am dedicated to the study of new therapies aimed at curing HIV, with special emphasis on the characterization, both in blood and in different tissues, of new cellular reservoirs of HIV and the development of strategies that enhance the immune system. Recently part of my research has been directed to the study of SARS-CoV-2.

Since 2015, I am the head of the HIV Translational Research Laboratory, located at the Vall d'Hebron Research Institute (VHIR), which belongs to the Infectious Diseases Department. I obtained my PhD in 2010 at AIDS Research Institute, Irsicaixa in Barcelona, and completed my postdoctoral training at the Ragon Institute of MGH, MIT and Harvard in Boston, where I was promoted to Instructor in Medicine at Harvard Medical School in 2014. My scientific interest has focused on the study of the HIV reservoirs that persist despite antiretroviral therapy (ART). I provided the first evidence that new rounds of cryptic viral replication were happening in the presence of ART (Nat Med 2010), and identified reservoir cells with stem-cell-like properties contributing to HIV long-term persistence (Nat Med 2014). My investigations are now focused on the characterization of new cellular reservoirs, the identification of novel latency reversal agents, and the design of new immune-targeted approximations aimed at depleting the latent reservoir. Recently, my lab has identified the new marker CD20 as a potential target for the transcriptionally active HIV reservoir (Nat Com 2019), has characterized the fraction of virus that can be awakened with current latency reversal agents in different populations (Plos Path 2019), and has developed new nanotechnological strategies for the elimination of the viral reservoir (NanoToday 2021). Besides, I am also a member of several evaluation panels (MINECO and AES grant calls), act as an abstract reviewer for several congresses (CROI, IAS and GESIDA), and participate in different scientific committees and international collaborative networks (BEAT-HIV Delaney Collaboratory Group). I have also contributed to innovation with 3 research patents. Importantly, I have been a recipient of several awards, including the CFAR Young Investigator Award (Harvard University Center for AIDS Research), the MGH ECOR Tosteson Award and the “International Raising Talents 2016” from the L'Oreal-Unesco Foundation For Women in Science.
A complete list of publications can be found here https://www.ncbi.nlm.nih.gov/myncbi/1TwfYvrCsLtkW/bibliography/public/

Projects

NEW APPROACHES TO LIMIT HIV PERSISTENCE BY MODULATING IMMUNOLOGICAL ENVIRONTMENTS

IP: María José Buzón Gómez
Collaborators: -
Funding agency: Fundació Institut de Recerca HUVH
Funding: 50649.27
Reference: VHIR/BEQUESPREDOC/2020/PEREA
Duration: 01/05/2021 - 30/04/2024

New therapeutic strategies directed to eliminate hiv in tissue reservoirs

IP: María José Buzón Gómez
Collaborators: Ana Gallego Cortes
Funding agency: Fundació "La Caixa"
Funding: 115092
Reference: LACAIXA/INPHINIT_INC/2020/BUZON
Duration: 01/10/2020 - 30/09/2023

NUEVAS ESTRATEGIAS TERAPEUTICAS DIRIGIDAS A LAS CELULAS NATURAL KILLERS PARA LA ELIMINACION DEL RESERVORIO LATENTE DEL VIH

IP: María José Buzón Gómez
Collaborators: -
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 98250
Reference: PRE2019-087393
Duration: 01/10/2020 - 30/09/2024

ADQUISICIÓN DE UN MICROSCOPIO CONFOCAL ESPECTRAL DE RASTREO DE ALTA RESOLUCIÓN DESTINADO A LA PLATAFORMA DE MICROSCOPÍA DE LA UNIDAD DE ALTA TECNOLOGÍA (UAT)

IP: Inmaculada Fuentes Camps
Collaborators: Miquel Vila Bover, ADQUISICIÓN DE UN MICROSCOPIO CONFOCAL ESPECTRAL DE RASTREO DE ALTA RESOLUCIÓN DESTINADO A LA PLATAFORMA DE MICROSCOPÍA DE LA UN, José García Arumí, Joan Gavaldà Santapau, Miguel Segura Ginard, ADQUISICIÓN DE UN MICROSCOPIO CONFOCAL ESPECTRAL DE RASTREO DE ALTA RESOLUCIÓN DESTINADO A LA PLATAFORMA DE MICROSCOPÍA DE LA UN, Victor Franco Puntes, Anna Santamaria Margalef, Carmen Espejo Ruiz, María José Buzón Gómez, Javier Inserte Igual, Anna Rosell Novel, Eduardo Fidel Tizzano, Trond Aasen
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 502000
Reference: EQC2019-006247-P
Duration: 01/01/2019 - 31/12/2020

Ministerio de Ciencia

Related news

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

More than 50 healthcare professionals and community agents in Benguela receive specialized training to improve the detection and support of women with perinatal disorders.

According to the results, the team highlights the need to use combinations of drugs to reactivate all HIV reservoirs and eliminate the virus from the different tissues where it remains silent.

Related professionals

Laia Aceituno Sierra

Laia Aceituno Sierra

Predoctoral researcher
Liver Diseases
Read more
Estefa Choque Apaico

Estefa Choque Apaico

Maintenance staff and general services
Infectious Diseases
Read more
Maria Garcia i Closa

Maria Garcia i Closa

Cardiovascular Diseases
Read more
Carlos Jimenez Padilla

Carlos Jimenez Padilla

Predoctoral researcher
Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.